Search
for
Sort by
Research 241–270 of 1000+
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Male pattern baldness and risk of colorectal neoplasia
- SOWBHAGYA CHUNDI LEGIYAM, A SIDDHA FORMULATION FOR THE HEALTH OF PUERPERAL WOMEN: A REVIEW
- Does Androgenic Alopecia Aggravate the Risk of Prostate Cancer? Evidence from Mendelian Randomization
- mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
- Implantation of Biocompatible Fibers for the Temporary Correction of Scalp Scars and Androgenetic Alopecia
- The pathophysiology of delayed ejaculation
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Regulatory roles of androgens in cutaneous wound healing
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Endocrinology of the Aging Prostate: Current Concepts
- Recent advances in treatment for Benign Prostatic Hyperplasia
- Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship?
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- TOXIC EPIDERMAL NECROLYSIS